Physician profile
Jacob E Markovitz
NPI 1790873891
$2,386.43
in general payments reported to CMS, 2019-2025
24 companies · $522 in 2025
The $522 reported for 2025 was more than what 81% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $290 · 2020: $822 · 2021: $110 · 2022: $341 · 2023: $146 · 2024: $155 · 2025: $522.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $823.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $822.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celularity INC. | $967.00 | 2019-2022 | |
| Avion Pharmaceuticals | $355.19 | 2019-2022 | |
| Medtronic, INC. | $341.46 | 2024-2025 | Propel, Truclear |
| Mayne Pharma Commercial LLC | $158.86 | 2023-2025 | |
| Abbvie INC. | $80.42 | 2019-2023 | |
| Allergan, INC. | $69.31 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $47.99 | 2019-2025 | Gardasil 9, Gardasil |
| Duchesnay USA Incorporated | $43.48 | 2019 | |
| Evofem Biosciences, INC. | $43.31 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $41.35 | 2023-2025 | |
| Smith+Nephew, INC. | $33.56 | 2025 | Pico 7 |
| Optumhealth Care Solutions, LLC | $30.41 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Astellas Pharma US INC | $28.38 | 2023-2024 | Veozah |
| Organon LLC | $22.65 | 2025 | Jada System |
| Meditrina | $16.71 | 2023 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $15.91 | 2024 | Summit Doppler |
| Takeda Pharmaceuticals U.S.A., INC. | $14.54 | 2024 | Vpriv |
| Strongbridge US INC. | $14.35 | 2020 | |
| Exeltis, USA INC. | $13.41 | 2019 | |
| Roche Diagnostics Corporation | $12.80 | 2019 | |
| Minerva Surgical, INC | $12.08 | 2019 | |
| Vertical Pharmaceuticals, LLC | $12.00 | 2019 | |
| Pfizer INC. | $11.26 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Markovitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.